growth hgh hormone human | Yeic.com 
http://www.yeic.com   
Web    News    Directory    Shopping













Articles on "growth+hgh+hormone+human"
PROLOR Biotech Awarded Two U.S. Patents For Its Longer-Acting Human Growth Hormone And Longer-Acting Erythropoietin
PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH), formerly Modigene Inc., announced that the U. S. Patent and Trademark Office (PTO) has issued two new patents for the company's long-acting CTP-enhanced human growth hormone (hGH-CTP) and human erythropoietin (EPO-CTP). The patents cover the composition of PROLOR's proprietary pharmaceutical compounds as well as certain associated methods.
Online Legal Steroids Announces HGH Factor: Non-Injectable Human Growth Hormone in Tablet Form
ST. PETERSBURG, FL--(Marketwire - July 1, 2009) - Online Legal Steroids, a leading online supplier of muscle enhancers, bodybuilding supplements and legal steroids products, has announced that a new product, HGH Factor , will be added to OnlineLegalSteroids.com. HGH for injection is one of the most expensive drugs in the United States, with a cost that can range between $800 and $3,000 per ...
Teva's Injection-Free Growth Hormone Shot Wins FDA Approval
(IsraelNN.com) Children requiring medication to increase their levels of human growth hormone (hGH) will no longer face the fright and pain of shots, thanks to FDA approval for a Teva Pharmaceuticals' hGH needle-free injection.
PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
ZIONA, Israel, June 30 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. , formerly Modigene Inc., today announced that the U. S. Patent and Trademark Office has issued two new patents for the company's long-acting CTP-enhanced human growth hormone and human erythropoietin .
Teva And Antares Announce FDA Approval Of Needle-Free Injector Product For Administration Of Tev-Tropin
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and its partner, Antares Pharma, Inc. (NYSE Amex: AIS) announced the approval of a Supplemental New Drug Application (sNDA), which added "needle-free injection" to its Tev-Tropin® [somatropin (rDNA) for injection] brand human growth hormone (hGH) drug label.
 
Powered by Yeic 1.0
Giant Spearfishing Forum